Health

Seegene Showcases HPV Diagnostic Kits and PCR Technology at AOGIN 2024

* Showcases Allplex™ HPV products designed to test for 14 high-risk HPV genotypes   * Advocates HPV testing for early diagnosis and prevention of cervical cancer  * Aims to accelerate the widespread adoption of syndromic PCR testing to create "a world free from all diseases" SEOUL, South Kore...

2024-07-16 21:00 2292

Yoshitsu Co., Ltd Reports Fiscal Year 2024 Financial Results

TOKYO, July 16, 2024 /PRNewswire/ -- Yoshitsu Co., Ltd ("Yoshitsu" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, as well as other products inHong Kong, Japan, North America, and the United...

2024-07-16 20:00 3461

Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials

SHANGHAI, July 16, 2024 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Medicine C...

2024-07-16 20:00 1780

Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics

MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced the expansion of its metabolite libr...

2024-07-16 19:45 1404

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 19:29 2116

3rd AUTISM EXPO Concludes Successfully with Celebration and Unity

SEOUL, South Korea, July 16, 2024 /PRNewswire/ -- The 3rd AUTISM EXPO 2024 concluded on a high note, featuring a wide range of exhibits and diverse events that attracted enthusiastic participation from individuals with developmental disabilities, their families, and related organizations.

2024-07-16 19:00 2200

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

SINGAPORE, July 16, 2024 /PRNewswire/ -- Biosyngen, a leading biotechnology company focused on the development of innovative cell therapies, recently announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) inChina has approved the initiation of a...

2024-07-16 17:10 2307

WIPO Honours Vivo Surgical with Global Accolade for Innovation and IP Excellence

Pioneering Singaporean surgical robotics company selected from over 660 applicants worldwide to emerge as a winner of the coveted WIPO Global Awards for 2024 GENEVA, July 16, 2024 /PRNewswire/ -- Vivo Surgical, a privately-held medical technology company pioneering a flexible endoscopic robot fo...

2024-07-16 16:45 15189

Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC

SHANGHAI, July 15, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been approved by the NMPA to enter Phase II clinical trial as monotherapy or in combination with a PD...

2024-07-15 22:00 1830

Everise launches EverAI Labs in partnership with GenAI industry experts Sharath Keshava and Dr. Andrew Maas

PALO ALTO, Calif., July 15, 2024 /PRNewswire/ -- Everise today announced its partnership withSharath Keshava, serial entrepreneur, to launch EverAI Labs. Aimed at transforming the complete agent journey and theUS$400 billion customer experience industry, EverAI Labs will unveil its integrated age...

2024-07-15 21:00 15489

In Honor of World Brain Day, the World Federation of Neurology to Host Free Public Webinar to Spotlight Brain Health and Disease Prevention

LONDON, July 15, 2024 /PRNewswire/ -- The World Federation of Neurology (WFN) is hosting its 11th annual World Brain Day on July 22. This year, World Brain Day will unite neurologists, patients, advocates and educators all over the world under the theme "Brain Health and Prevention."

2024-07-15 20:30 2645

CeraVe Releases "Cleanse Like a Derm - a CeraVe Soap Opera" Starring Xochitl Gomez

The Daytime Television Inspired Campaign Aims to Educate Consumers on Proper Cleansing Habits with CeraVe's Dermatologist-Recommended Products NEW YORK, July 15, 2024 /PRNewswire/ -- Secrets and ceramides and double-crossing dermatologists, oh my! CeraVe, the #1 dermatologist-recommended skincar...

2024-07-15 20:00 2325

United Imaging Announces First PET/CT Installation in Mexico, at Instituto Nacional de Pediatría

MEXICO CITY, July 15, 2024 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has launched its uMI 550 PET/CT system at the Instituto Nacional de Pediatría (INP) inMexico. This partnership reflects a shared commitment between the two organizati...

2024-07-15 20:00 1141

I-Mab Announces Leadership Transitions

ROCKVILLE, Md., July 15, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company" or "I-Mab"), a U.S.-based, global biotech company, announced today that the Board of Directors of the Company has appointed Mr.Wei Fu as the Chairman of the Board of Directors. He succeeds Dr.Pamela M. Klein, who st...

2024-07-15 19:30 1701

HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer

ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofChristopher W. Slavinsky as Chief Business Development and Legal Officer. HanAll Biopharma Appoints Christopher...

2024-07-15 19:00 1604

Smart Binhai, Glorious Competition! 2024 China Tianjin Binhai New Area Talent Innovation and Entrepreneurship Competition (Overseas Competition) Hong Kong SAR Division Finals to Begin Soon

HONG KONG, July 15, 2024 /PRNewswire/ -- With the surging waves of global innovations, the 2024 China Tianjin Binhai New Area Talent Innovation and Entrepreneurship Competition (Overseas Competition) Hong Kong SAR Division Finals will soon kick off in Hong Kong SAR on 17th July 2024. As the gatew...

2024-07-15 17:43 1631

CooperVision Champions Children's Eye Health at WCPOS V 2024

Global Myopia Management Leader Showcases Long-Term Benefits of MiSight® 1 day KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- CooperVision , a global leader in myopia management, successfully concluded its impactful participation as a Gold sponsor at the5

2024-07-15 14:00 8110

CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area

SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...

2024-07-15 13:59 1766

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...

2024-07-15 13:44 1835

Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1

SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...

2024-07-15 12:17 3208
1 ... 56575859606162 ... 858